Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METHOCARBAMOL Cause Therapy non-responder? 24 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Therapy non-responder have been filed in association with METHOCARBAMOL (Methocarbamol Tablets, USP, 500 mg). This represents 1.1% of all adverse event reports for METHOCARBAMOL.

24
Reports of Therapy non-responder with METHOCARBAMOL
1.1%
of all METHOCARBAMOL reports
2
Deaths
5
Hospitalizations

How Dangerous Is Therapy non-responder From METHOCARBAMOL?

Of the 24 reports, 2 (8.3%) resulted in death, 5 (20.8%) required hospitalization, and 2 (8.3%) were considered life-threatening.

Is Therapy non-responder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METHOCARBAMOL. However, 24 reports have been filed with the FAERS database.

What Other Side Effects Does METHOCARBAMOL Cause?

Drug ineffective (294) Completed suicide (277) Toxicity to various agents (166) Drug hypersensitivity (162) Drug dependence (130) Drug abuse (121) Hypertension (119) Off label use (105) Respiratory depression (104) Nausea (95)

What Other Drugs Cause Therapy non-responder?

ETANERCEPT (3,472) APREMILAST (3,360) METHOTREXATE (2,965) RITUXIMAB (2,731) ADALIMUMAB (2,595) PREDNISONE (2,563) TREPROSTINIL (2,289) INFLIXIMAB (2,122) TOCILIZUMAB (1,775) HYDROXYCHLOROQUINE (1,699)

Which METHOCARBAMOL Alternatives Have Lower Therapy non-responder Risk?

METHOCARBAMOL vs METHOHEXITAL METHOCARBAMOL vs METHOTREXATE METHOCARBAMOL vs METHOXSALEN METHOCARBAMOL vs METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA METHOCARBAMOL vs METHYL ALCOHOL

Related Pages

METHOCARBAMOL Full Profile All Therapy non-responder Reports All Drugs Causing Therapy non-responder METHOCARBAMOL Demographics